Krane Funds Advisors’s Zai Lab ZLAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-34,357
Closed -$1.27M 120
2023
Q1
$1.27M Sell
34,357
-3,090
-8% -$119K 0.06% 31
2022
Q4
$1.15M Sell
37,447
-3,438
-8% -$108K 0.05% 30
2022
Q3
$1.4M Buy
40,885
+694
+2% +$29.7K 0.07% 38
2022
Q2
$1.39M Buy
40,191
+2,742
+7% +$96.7K 0.05% 41
2022
Q1
$1.65M Buy
37,449
+3,315
+10% +$160K 0.07% 49
2021
Q4
$2.15M Sell
34,134
-9,888
-22% -$838K 0.05% 56
2021
Q3
$4.64M Sell
44,022
-2,060
-4% -$296K 0.1% 45
2021
Q2
$8.16M Buy
46,082
+1,732
+4% +$279K 0.24% 39
2021
Q1
$5.92M Buy
44,350
+12,976
+41% +$2.01M 0.22% 36
2020
Q4
$4.25M Buy
31,374
+8,238
+36% +$839K 0.17% 31
2020
Q3
$1.92M Buy
23,136
+7,880
+52% +$633K 0.09% 28
2020
Q2
$1.25M Buy
15,256
+8,366
+121% +$566K 0.08% 40
2020
Q1
$355K Buy
6,890
+6,790
+6,790% +$354K 0.02% 185
2019
Q4
$4K Sell
100
-55
-35% -$2.03K ﹤0.01% 221
2019
Q3
$5K Hold
155
﹤0.01% 217
2019
Q2
$5K Buy
+155
New +$4.57K ﹤0.01% 208

Other funds holding ZLAB

Krane Funds Advisors's ZLAB Position: Q2 2023 in Review

Krane Funds Advisors sold out of Zai Lab (ZLAB) in Q2 2023, closing a stake of 34,357 shares — an estimated $1.27M sold.

Krane Funds Advisors first reported a position in ZLAB in Q2 2019 and held it in 16 quarters. The position peaked at $8.16M in Q2 2021. 137 funds tracked by Wall St. Rank hold ZLAB as of Q2 2023.

  • Krane Funds Advisors reported no remaining Zai Lab position as of Q2 2023 after selling out during the quarter.
  • Krane Funds Advisors sold 34,357 Zai Lab shares in Q2 2023, an estimated $1.27M.
  • Krane Funds Advisors first reported a position in Zai Lab in Q2 2019 and held it in 16 quarters.
  • Krane Funds Advisors's Zai Lab position peaked at $8.16M in Q2 2021.
  • 137 funds tracked by Wall St. Rank held Zai Lab as of Q2 2023.

Based on Krane Funds Advisors's 13F filing for Q2 2023, filed 11 Aug 2023.